https://doi.org/10.1016/j.ebiom.2020.103053
S
Sally Shin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
4.4K
Citations
21
h-index
28
i10-index
Sally Shin is an academic researcher from Ragon Institute of MGH, MIT and Harvard. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 21, co-authored 36 publications.
ORCID: 0000-0002-9306-2264Papers by this author
worksAn observational study identifying highly tuberculosis-exposed, HIV-1-positive but persistently TB, tuberculin and IGRA negative persons with M. tuberculosis specific antibodies in Cape Town, South Africa
2020 · EBioMedicine · 46 citations
Selective transfer of maternal antibodies in preterm and fullterm children
2022 · Scientific Reports · 30 citations
https://doi.org/10.1038/s41598-022-18973-4
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy
2022 · Cell Reports Medicine · 29 citations
https://doi.org/10.1016/j.xcrm.2022.100811
Robust induction of functional humoral response by a plant-derived Coronavirus-like particle vaccine candidate for COVID-19
2023 · npj Vaccines · 5 citations
https://doi.org/10.1038/s41541-023-00612-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat